Comparison of Different Modeling Approaches for Prescription Opioid Use and Its Association With Adverse Events.


Journal

American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653

Informations de publication

Date de publication:
01 09 2023
Historique:
received: 01 08 2021
revised: 30 01 2023
accepted: 05 05 2023
medline: 4 9 2023
pubmed: 16 5 2023
entrez: 16 5 2023
Statut: ppublish

Résumé

Previous research linking opioid prescribing to adverse drug events has failed to properly account for the time-varying nature of opioid exposure. This study aimed to explore how the risk of opioid-related emergency department visits, readmissions, or deaths (composite outcome) varies with opioid dose and duration, comparing different novel modeling techniques. A prospective cohort of 1,511 hospitalized patients discharged from 2 McGill-affiliated hospitals in Montreal, 2014-2016, was followed from the first postdischarge opioid dispensation until 1 year after discharge. Marginal structural Cox proportional hazards models and their flexible extensions were used to explore the association between time-varying opioid use and the composite outcome. Weighted cumulative exposure models assessed cumulative effects of past use and explored how its impact depends on the recency of exposure. The patient mean age was 69.6 (standard deviation = 14.9) years; 57.7% were male. In marginal structural model analyses, current opioid use was associated with a 71% increase in the hazard of opioid-related adverse events (adjusted hazard ratio = 1.71, 95% confidence interval: 1.21, 2.43). The weighted cumulative exposure results suggested that the risk cumulates over the previous 50 days of opioid consumption. Flexible modeling techniques helped assess how the risk of opioid-related adverse events may be associated with time-varying opioid exposures while accounting for nonlinear relationships and the recency of past use.

Identifiants

pubmed: 37191340
pii: 7163022
doi: 10.1093/aje/kwad115
pmc: PMC10472496
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1592-1603

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.

Références

Anasthesiol Intensivmed Notfallmed Schmerzther. 2003 Jan;38(1):14-26
pubmed: 12522725
Am J Epidemiol. 2019 Aug 1;188(8):1552-1562
pubmed: 31107497
JAMA. 2016 Apr 19;315(15):1624-45
pubmed: 26977696
Int J Biostat. 2010;6(2):Article 13
pubmed: 21969997
Lancet. 2019 Apr 13;393(10180):1558-1568
pubmed: 30983591
JAMA Intern Med. 2016 Sep 1;176(9):1286-93
pubmed: 27400458
Pain. 2004 Dec;112(3):372-380
pubmed: 15561393
J Pain. 2016 Apr;17(4):436-43
pubmed: 26721613
J Gen Intern Med. 2016 May;31(5):478-85
pubmed: 26553336
Am J Epidemiol. 2008 Feb 15;167(4):492-9
pubmed: 18056625
AAPS J. 2008 Dec;10(4):537-51
pubmed: 18989788
J Psychosom Res. 2012 Jun;72(6):443-51
pubmed: 22656441
Can Fam Physician. 2014 Sep;60(9):826-32
pubmed: 25217680
PLoS One. 2017 Feb 3;12(2):e0171723
pubmed: 28158269
Geriatr Nurs. 2019 Mar - Apr;40(2):190-196
pubmed: 30401575
Pain Med. 2016 Jan;17(1):85-98
pubmed: 26333030
PLoS One. 2016 Dec 14;11(12):e0167479
pubmed: 27973601
Dtsch Arztebl Int. 2014 Oct 24;111(43):732-40
pubmed: 25404530
Healthc Q. 2016;18(4):8-11
pubmed: 27009700
Pain Res Manag. 2013 Jul-Aug;18(4):177-84
pubmed: 23717824
Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):4-12
pubmed: 29862602
Stat Med. 2007 Jan 30;26(2):392-408
pubmed: 16479552
Palliat Med. 2011 Oct;25(7):725-32
pubmed: 21378066
J Am Coll Surg. 2003 Feb;196(2):321-4
pubmed: 12595060
J Neurosurg Anesthesiol. 2021 Jul 1;33(3):212-220
pubmed: 31834247
BMC Geriatr. 2019 Jul 5;19(1):185
pubmed: 31277582
J Opioid Manag. 2012 May-Jun;8(3):153-60
pubmed: 22798175
Med Care. 2010 Jun;48(6 Suppl):S114-20
pubmed: 20473199
Am J Epidemiol. 2008 Sep 15;168(6):656-64
pubmed: 18682488
J Pain. 2016 Feb;17(2):131-57
pubmed: 26827847
N Engl J Med. 2014 May 29;370(22):2063-6
pubmed: 24758595
J Hosp Med. 2018 Apr;13(4):243-248
pubmed: 29624187
JAMA Surg. 2017 Jun 21;152(6):e170504
pubmed: 28403427
Anesth Analg. 2018 Jul;127(1):247-254
pubmed: 29570151
BMJ. 2018 Jan 17;360:j5790
pubmed: 29343479
Health Promot Chronic Dis Prev Can. 2018 Jun;38(6):224-233
pubmed: 29911818
Med Care. 2013 Oct;51(10):870-8
pubmed: 24025657
J Opioid Manag. 2008 May-Jun;4(3):123-30
pubmed: 18717507
Stat Med. 2012 May 20;31(11-12):1014-30
pubmed: 22095719
JAMA Netw Open. 2019 Sep 4;2(9):e1910756
pubmed: 31539073
J Pain. 2017 Aug;18(8):956-963
pubmed: 28347798
Pain Rep. 2017 Mar 06;2(2):e589
pubmed: 29392205
Acad Emerg Med. 2016 Feb;23(2):151-8
pubmed: 26824227
J Pain. 2017 Nov;18(11):1374-1383
pubmed: 28711636
Pain Physician. 2011 Mar-Apr;14(2):91-121
pubmed: 21412367
Am J Epidemiol. 2005 Sep 1;162(5):471-8
pubmed: 16076835
Drug Alcohol Depend. 2018 Oct 1;191:348-354
pubmed: 30176548
Anesthesiology. 2016 Feb;124(2):483-8
pubmed: 26594912
Curr Epidemiol Rep. 2015 Dec;2(4):221-228
pubmed: 26954351
JAMA Intern Med. 2013 Feb 11;173(3):196-201
pubmed: 23318919
J Opioid Manag. 2016 Nov/Dec;12(6):377-387
pubmed: 28059430
Stat Med. 2009 Nov 30;28(27):3437-53
pubmed: 19708037
Arch Intern Med. 2011 Apr 11;171(7):686-91
pubmed: 21482846
BMJ. 2011 Aug 23;343:d5142
pubmed: 21862533
Lancet. 2019 Apr 13;393(10180):1547-1557
pubmed: 30983590
J Clin Epidemiol. 2006 Apr;59(4):393-403
pubmed: 16549262
Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):148-160
pubmed: 29285840
Drug Alcohol Depend. 2018 Oct 1;191:86-90
pubmed: 30096638
Schmerz. 2018 Dec;32(6):419-426
pubmed: 30242530
JMIR Public Health Surveill. 2018 Feb 27;4(1):e21
pubmed: 29487041
Epidemiology. 2000 Sep;11(5):561-70
pubmed: 10955409
J Pain. 2010 Nov;11(11):1095-108
pubmed: 20452835
Stat Med. 2014 Aug 30;33(19):3318-37
pubmed: 24757068
CMAJ. 2017 May 8;189(18):E659-E666
pubmed: 28483845
Lancet. 2019 Apr 13;393(10180):1478
pubmed: 30983571

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH